XML 93 R81.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 10 - Commitments and Contingencies (Details Textual)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
shares
Jun. 30, 2015
USD ($)
Dec. 31, 2015
CAD
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
Employment [Member]              
Compensation         CAD 19 $ 6,489  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares         75,000 75,000  
Stock Issued During Period, Value, Stock Options Exercised           $ 64,223  
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)           $ 53,519  
Consultant [Member] | Employee Stock Option [Member]              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term         10 years 10 years  
Consultant [Member]              
Compensation | CAD         CAD 1,000    
Stock Issued During Period, Value, Stock Options Exercised           $ 42,816  
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)           $ 35,680  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares         100,000 100,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares           4,167  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares           $ 1  
Research and Development Expense           $ 10,861 $ 11,650
Operating Leases, Rent Expense           430  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares     133,229        
Research and Development Expense $ 374,206 $ 39,975 $ 422,721 $ 61,424   $ 456,274 $ 191,069